SCOPUS 정보 검색 플랫폼

Journal of the National Cancer Institute

Volumn 96, Issue 4, 2004, Pages 338-339

Male breast cancer during finasteride therapy [4]

(2) Lee, Shen C a Ellis, Robert J b

a Missouri University of Science and Technology (United States)

b Oncology and Hematology Associates (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BOLDENONE; DOXAZOSIN; ESTROGEN; FINASTERIDE; STEROID 5ALPHA REDUCTASE;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; GYNECOMASTIA; HORMONE DETERMINATION; HUMAN; KLINEFELTER SYNDROME; LETTER; MALE; MALE BREAST; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 1342333702 PISSN: 00278874 EISSN: None Source Type: Journal
DOI: 10.1093/jnci/djh062 Document Type: Letter

Times cited : (25)

References (7)

1
- 0003361964
- Male breast cancer
- Harris JR, Lippman ME, Morrow M, Osborn CK, editors. 2nd ed. Philadelphia (PA): Lippincott
- Gradishar WJ. Male breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborn CK, editors. Diseases of the breast. 2nd ed. Philadelphia (PA): Lippincott; 2000. p. 661-7.
- (2000) Diseases of the Breast , pp. 661-667
- Gradishar, W.J.¹

2
- 0037125379
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
- Roussouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stafanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288: 321-33.
- (2002) JAMA , vol.288 , pp. 321-333
- Roussouw, J.E.¹ Anderson, G.L.² Prentice, R.L.³ LaCroix, A.Z.⁴ Kooperberg, C.⁵ Stafanick, M.L.⁶

3
- 0027403583
- Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors
- Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53: 538-49.
- (1993) Int. J. Cancer , vol.53 , pp. 538-549
- Sasco, A.J.¹ Lowenfels, A.B.² Pasker-de Jong, P.³

4
- 0037108651
- Breast cancer in men
- Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002; 137:678-87.
- (2002) Ann. Intern. Med. , vol.137 , pp. 678-687
- Giordano, S.H.¹ Buzdar, A.U.² Hortobagyi, G.N.³

5
- 0029835393
- Gynecomastia and breast cancer during finasteride therapy
- Green L, Wysowski DK, Fourcroy JL. Gynecomastia and breast cancer during finasteride therapy. N Engl J Med 1996;335:823.
- (1996) N. Engl. J. Med. , vol.335 , pp. 823
- Green, L.¹ Wysowski, D.K.² Fourcroy, J.L.³

6
- 0037812658
- The influence of finasteride on the development of prostate cancer
- Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349: 215-24.
- (2003) N. Engl. J. Med. , vol.349 , pp. 215-224
- Thompson, I.M.¹ Goodman, P.J.² Tangen, C.M.³ Lucia, M.S.⁴ Miller, G.J.⁵ Ford, L.G.⁶

7
- 0347882750
- The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
- McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387-2398.
- (2003) N. Engl. J. Med. , vol.349 , pp. 2387-2398
- McConnell, J.D.¹ Roehrborn, C.G.² Bautista, O.M.³ Andriole Jr., G.L.⁴ Dixon, C.M.⁵ Kusek, J.W.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.